Drug Shortage Report for SANDOZ LOSARTAN

Last updated on 2020-07-14 History
Report ID 73167
Drug Identification Number 02313340
Brand name SANDOZ LOSARTAN
Common or Proper name LOSARTAN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LOSARTAN POTASSIUM
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date 2020-07-06
Actual end date 2020-06-01
Shortage status Resolved
Updated date 2020-07-14
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-01-21 English Compare
v2 2019-01-21 French Compare
v3 2020-04-06 English Compare
v4 2020-04-06 French Compare
v5 2020-07-14 English Compare
v6 2020-07-14 French Compare